Recent clinical information suggests that Novera Retatrutide, a combined-action therapy from Novo Nordisk, could offer a substantial breakthrough in weight management. Differing from many existing treatments, Retatrutide targets both GLP-1 and the GIP hormone, potentially leading to enhanced loss… Read More